De novo protein design enables the precise induction of RSV-neutralizing antibodies

De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines...

Full description

Saved in:
Bibliographic Details
Published in:IDEAS Working Paper Series from RePEc Vol. 368; no. 6492
Main Authors: Sesterhenn, Fabian, Yang, Che, Bonet, Jaume, Cramer, Johannes T, Wen, Xiaolin, Wang, Yimeng, Chiang, Chi-I, Abriata, Luciano A, Kucharska, Iga, Castoro, Giacomo, Vollers, Sabrina S, Galloux, Marie, Dheilly, Elie, Rosset, Stéphane, Corthésy, Patricia, Georgeon, Sandrine, Villard, Mélanie, Richard, Charles-Adrien, Descamps, Delphyne, Delgado, Teresa, Oricchio, Elisa, Rameix-Welti, Marie-Anne, Más, Vicente, Ervin, Sean, Eléouët, Jean-François, Riffault, Sabine, Bates, John T, Julien, Jean-Philippe, Li, Yuxing, Jardetzky, Theodore, Krey, Thomas, Correia, Bruno E
Format: Journal Article Paper
Language:English
Published: United States Federal Reserve Bank of St. Louis 15.05.2020
Subjects:
ISSN:1095-9203, 1095-9203
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs.
AbstractList De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs.De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs.
De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs. Copyright
De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs.
Author Corthésy, Patricia
Yang, Che
Eléouët, Jean-François
Bates, John T
Más, Vicente
Kucharska, Iga
Cramer, Johannes T
Chiang, Chi-I
Castoro, Giacomo
Rameix-Welti, Marie-Anne
Wen, Xiaolin
Li, Yuxing
Galloux, Marie
Georgeon, Sandrine
Richard, Charles-Adrien
Jardetzky, Theodore
Vollers, Sabrina S
Oricchio, Elisa
Descamps, Delphyne
Julien, Jean-Philippe
Krey, Thomas
Bonet, Jaume
Villard, Mélanie
Wang, Yimeng
Sesterhenn, Fabian
Ervin, Sean
Dheilly, Elie
Riffault, Sabine
Correia, Bruno E
Delgado, Teresa
Abriata, Luciano A
Rosset, Stéphane
Author_xml – sequence: 1
  givenname: Fabian
  orcidid: 0000-0001-8331-4344
  surname: Sesterhenn
  fullname: Sesterhenn, Fabian
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 2
  givenname: Che
  orcidid: 0000-0002-4591-5373
  surname: Yang
  fullname: Yang, Che
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 3
  givenname: Jaume
  orcidid: 0000-0001-5210-4387
  surname: Bonet
  fullname: Bonet, Jaume
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 4
  givenname: Johannes T
  orcidid: 0000-0002-2595-3188
  surname: Cramer
  fullname: Cramer, Johannes T
  organization: Institute of Virology, Hannover Medical School, Hannover 30625, Germany
– sequence: 5
  givenname: Xiaolin
  orcidid: 0000-0001-5238-9685
  surname: Wen
  fullname: Wen, Xiaolin
  organization: Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
– sequence: 6
  givenname: Yimeng
  orcidid: 0000-0003-0790-1277
  surname: Wang
  fullname: Wang, Yimeng
  organization: Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA
– sequence: 7
  givenname: Chi-I
  surname: Chiang
  fullname: Chiang, Chi-I
  organization: Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA
– sequence: 8
  givenname: Luciano A
  orcidid: 0000-0003-3087-8677
  surname: Abriata
  fullname: Abriata, Luciano A
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 9
  givenname: Iga
  surname: Kucharska
  fullname: Kucharska, Iga
  organization: Departments of Biochemistry and Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
– sequence: 10
  givenname: Giacomo
  surname: Castoro
  fullname: Castoro, Giacomo
  organization: Institute of Virology, Hannover Medical School, Hannover 30625, Germany
– sequence: 11
  givenname: Sabrina S
  orcidid: 0000-0002-6772-0155
  surname: Vollers
  fullname: Vollers, Sabrina S
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 12
  givenname: Marie
  surname: Galloux
  fullname: Galloux, Marie
  organization: Université Paris-Saclay, INRAE, UVSQ, VIM, 78350 Jouy-en-Josas, France
– sequence: 13
  givenname: Elie
  surname: Dheilly
  fullname: Dheilly, Elie
  organization: Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland
– sequence: 14
  givenname: Stéphane
  orcidid: 0000-0002-8443-6017
  surname: Rosset
  fullname: Rosset, Stéphane
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 15
  givenname: Patricia
  surname: Corthésy
  fullname: Corthésy, Patricia
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 16
  givenname: Sandrine
  orcidid: 0000-0002-8158-4508
  surname: Georgeon
  fullname: Georgeon, Sandrine
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 17
  givenname: Mélanie
  orcidid: 0000-0002-1306-4324
  surname: Villard
  fullname: Villard, Mélanie
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
– sequence: 18
  givenname: Charles-Adrien
  surname: Richard
  fullname: Richard, Charles-Adrien
  organization: Université Paris-Saclay, INRAE, UVSQ, VIM, 78350 Jouy-en-Josas, France
– sequence: 19
  givenname: Delphyne
  orcidid: 0000-0002-4883-6910
  surname: Descamps
  fullname: Descamps, Delphyne
  organization: Université Paris-Saclay, INRAE, UVSQ, VIM, 78350 Jouy-en-Josas, France
– sequence: 20
  givenname: Teresa
  surname: Delgado
  fullname: Delgado, Teresa
  organization: Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Madrid, Spain
– sequence: 21
  givenname: Elisa
  orcidid: 0000-0002-1690-0447
  surname: Oricchio
  fullname: Oricchio, Elisa
  organization: Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland
– sequence: 22
  givenname: Marie-Anne
  orcidid: 0000-0002-5901-3856
  surname: Rameix-Welti
  fullname: Rameix-Welti, Marie-Anne
  organization: UMR1173, INSERM, Université de Versailles St. Quentin, 78180 Montigny le Bretonneux, France
– sequence: 23
  givenname: Vicente
  surname: Más
  fullname: Más, Vicente
  organization: Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Madrid, Spain
– sequence: 24
  givenname: Sean
  orcidid: 0000-0001-8433-5382
  surname: Ervin
  fullname: Ervin, Sean
  organization: Wake Forest Baptist Medical Center, Winston Salem, NC 27157, USA
– sequence: 25
  givenname: Jean-François
  orcidid: 0000-0002-7361-4885
  surname: Eléouët
  fullname: Eléouët, Jean-François
  organization: Université Paris-Saclay, INRAE, UVSQ, VIM, 78350 Jouy-en-Josas, France
– sequence: 26
  givenname: Sabine
  surname: Riffault
  fullname: Riffault, Sabine
  organization: Université Paris-Saclay, INRAE, UVSQ, VIM, 78350 Jouy-en-Josas, France
– sequence: 27
  givenname: John T
  orcidid: 0000-0001-5545-6871
  surname: Bates
  fullname: Bates, John T
  organization: University of Mississippi Medical Center, Jackson, MS 39216, USA
– sequence: 28
  givenname: Jean-Philippe
  orcidid: 0000-0001-7602-3995
  surname: Julien
  fullname: Julien, Jean-Philippe
  organization: Departments of Biochemistry and Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
– sequence: 29
  givenname: Yuxing
  surname: Li
  fullname: Li, Yuxing
  organization: Department of Microbiology and Immunology & Center of Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
– sequence: 30
  givenname: Theodore
  orcidid: 0000-0002-3664-0072
  surname: Jardetzky
  fullname: Jardetzky, Theodore
  organization: Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
– sequence: 31
  givenname: Thomas
  orcidid: 0000-0002-4548-7241
  surname: Krey
  fullname: Krey, Thomas
  organization: Centre for Structural Systems Biology (CSSB), 22607 Hamburg, Germany
– sequence: 32
  givenname: Bruno E
  orcidid: 0000-0002-7377-8636
  surname: Correia
  fullname: Correia, Bruno E
  email: bruno.correia@epfl.ch
  organization: Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32409444$$D View this record in MEDLINE/PubMed
BookMark eNpdkMtLAzEQxoNU7EPP3iTgxcvWvHa7OUp9QkGw6nXJJpOask3qZleof70RK4jMwMwwPz6-mTEa-OABoVNKppSy4jJqB17DVKldTnJ6gEaUyDyTjPDBn36IxjGuCUmz5EdoyJkgUggxQstrwD58BLxtQwfOYwPRrTwGr-oGIu7eIK1AuwjYedPrzgWPg8VPy9fMQ9-1qnGfzq-w8p2rg3EQj9GhVU2Ek32doJfbm-f5fbZ4vHuYXy0ynQvZZaa2xApQTAsimC2IobWwxtK6FCkpsTNhlSgpMaRUkmk141ZTa6HgOZfAJ-jiRzd5f-8hdtXGRQ1NozyEPlbpyBQFK1lCz_-h69C3PrmrWF4WeSEJ_6bO9lRfb8BU29ZtVLurft_FvwDt5G--
CitedBy_id crossref_primary_10_1038_s41598_025_94295_5
crossref_primary_10_1093_bib_bbac102
crossref_primary_10_1016_j_sbi_2022_102370
crossref_primary_10_1038_s41587_024_02127_0
crossref_primary_10_1002_pro_4653
crossref_primary_10_1016_j_biotechadv_2021_107793
crossref_primary_10_1073_pnas_2206111119
crossref_primary_10_1038_s41541_021_00417_1
crossref_primary_10_1038_s41422_020_0366_x
crossref_primary_10_1073_pnas_2117401119
crossref_primary_10_1017_S0033583524000131
crossref_primary_10_1016_j_ijbiomac_2021_10_172
crossref_primary_10_1111_all_15066
crossref_primary_10_1007_s11427_023_2322_3
crossref_primary_10_3389_fimmu_2021_683902
crossref_primary_10_1016_j_cels_2023_10_006
crossref_primary_10_1016_j_copbio_2022_102821
crossref_primary_10_1016_j_techfore_2023_122588
crossref_primary_10_1016_j_immuni_2023_01_013
crossref_primary_10_1002_jmv_26453
crossref_primary_10_2174_0929867330666230602143700
crossref_primary_10_2174_1381612828666220701160116
crossref_primary_10_1016_j_omtm_2025_101535
crossref_primary_10_1039_D0RA08222H
crossref_primary_10_1016_j_coviro_2023_101337
crossref_primary_10_3390_s20154289
crossref_primary_10_1073_pnas_2307371120
crossref_primary_10_3390_vaccines9010059
crossref_primary_10_1093_protein_gzab029
crossref_primary_10_1038_s41589_020_00699_x
crossref_primary_10_1093_protein_gzab027
crossref_primary_10_3389_fimmu_2022_941865
crossref_primary_10_3389_fbioe_2020_568318
crossref_primary_10_1038_s41541_023_00792_x
crossref_primary_10_1007_s11427_022_2214_2
crossref_primary_10_3390_biology12020166
crossref_primary_10_1126_science_abe0075
crossref_primary_10_1371_journal_pcbi_1009178
crossref_primary_10_3390_idr16050081
crossref_primary_10_1109_JPROC_2022_3157898
crossref_primary_10_3390_v17030417
crossref_primary_10_1038_s41586_025_09122_8
crossref_primary_10_1016_j_ebiom_2025_105638
crossref_primary_10_1038_s41590_024_01833_w
crossref_primary_10_1038_s41594_023_01029_0
crossref_primary_10_1038_s41598_021_81895_0
crossref_primary_10_1038_s41594_023_01147_9
crossref_primary_10_1038_s41541_021_00347_y
crossref_primary_10_1093_bioadv_vbad072
crossref_primary_10_3390_life11030225
crossref_primary_10_1007_s00203_022_03133_z
crossref_primary_10_1016_j_apsb_2025_07_015
crossref_primary_10_1107_S2059798321005787
crossref_primary_10_1016_j_it_2021_01_001
crossref_primary_10_1093_protein_gzab007
crossref_primary_10_1016_j_tibs_2024_07_006
crossref_primary_10_1016_j_fmre_2021_01_011
crossref_primary_10_3390_ijms241310583
crossref_primary_10_1038_s41580_024_00718_y
crossref_primary_10_1007_s41061_024_00469_6
crossref_primary_10_1016_j_sbi_2021_02_002
crossref_primary_10_59717_j_xinn_life_2025_100133
crossref_primary_10_1038_s41586_023_05993_x
crossref_primary_10_1002_adbi_202000181
crossref_primary_10_1016_j_cell_2021_05_001
crossref_primary_10_1080_17460441_2022_2123468
crossref_primary_10_1021_jacs_5c11289
crossref_primary_10_1038_s43586_025_00383_1
crossref_primary_10_1016_j_jmb_2021_167093
crossref_primary_10_1093_synbio_ysab005
crossref_primary_10_1002_jmv_70004
crossref_primary_10_1002_pro_5095
crossref_primary_10_1038_s41573_022_00495_3
crossref_primary_10_1016_j_ijbiomac_2022_10_031
crossref_primary_10_1038_s41586_023_06415_8
crossref_primary_10_1016_j_vaccine_2024_05_038
crossref_primary_10_1016_j_ijbiomac_2022_06_154
crossref_primary_10_1080_22221751_2024_2447615
crossref_primary_10_1016_j_sbi_2020_10_015
crossref_primary_10_1038_s41579_020_0391_2
crossref_primary_10_3390_v13122478
crossref_primary_10_1016_j_str_2024_07_016
crossref_primary_10_1093_nar_gkae386
crossref_primary_10_3389_fimmu_2021_677027
crossref_primary_10_1016_j_jmb_2021_167160
crossref_primary_10_1016_j_smim_2020_101428
crossref_primary_10_1038_s44321_024_00123_0
crossref_primary_10_1007_s12250_020_00283_6
crossref_primary_10_1002_pro_4713
crossref_primary_10_1016_j_lfs_2021_119695
crossref_primary_10_1038_s44320_024_00037_6
crossref_primary_10_1080_08830185_2024_2374546
crossref_primary_10_1126_science_abj3321
crossref_primary_10_1371_journal_pone_0256895
crossref_primary_10_1038_s41587_024_02133_2
crossref_primary_10_1038_s41594_021_00596_4
crossref_primary_10_1016_j_molimm_2022_03_006
crossref_primary_10_1038_s41592_021_01097_4
crossref_primary_10_1371_journal_ppat_1010518
crossref_primary_10_3390_vaccines8040694
crossref_primary_10_1002_prot_26847
crossref_primary_10_1186_s12951_025_03200_9
crossref_primary_10_1016_j_sbi_2021_01_007
crossref_primary_10_1016_j_jmb_2021_167154
crossref_primary_10_1007_s00103_021_03477_9
crossref_primary_10_1002_pro_3970
crossref_primary_10_3390_v13071320
crossref_primary_10_1016_j_bej_2021_108096
crossref_primary_10_1038_s41467_022_28601_4
crossref_primary_10_1126_science_abn2100
crossref_primary_10_3389_fbioe_2021_705534
crossref_primary_10_1128_MMBR_00078_20
ContentType Journal Article
Paper
Copyright Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
2020. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://research.stlouisfed.org/research_terms.html .
Copyright_xml – notice: Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
– notice: 2020. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://research.stlouisfed.org/research_terms.html .
DBID CGR
CUY
CVF
ECM
EIF
NPM
3V.
7WY
7WZ
7XB
87Z
8FK
8FL
AAFGM
ABLUL
ABPUF
ABSSA
ABUWG
ACIOU
ADZZV
AFKRA
AGAJT
AGSBL
AJNOY
AQTIP
AZQEC
BENPR
BEZIV
BOUDT
CBHQV
CCPQU
DWQXO
FRNLG
F~G
K60
K6~
L.-
M0C
PHGZM
PHGZT
PIMPY
PKEHL
PQBIZ
PQBZA
PQCXX
PQEST
PQQKQ
PQUKI
Q9U
7X8
DOI 10.1126/science.aay5051
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest ABI/INFORM Collection
ABI/INFORM Global (PDF only)
ProQuest Central (purchase pre-March 2016)
ABI/INFORM Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
ABI/INFORM Collection (Alumni)
ProQuest Central Korea - hybrid linking
Business Premium Collection - hybrid linking
ABI/INFORM Collection (Alumni) - hybrid linking
ABI/INFORM Collection - hybrid linking
ProQuest Central (Alumni)
ABI/INFORM Global - hybrid linking
ProQuest Central (Alumni) - hybrid linking
ProQuest Central UK/Ireland
ProQuest Central Essentials - hybrid linking
ABI/INFORM Global (Alumni) - hybrid linking
Business Premium Collection (Alumni) - hybrid linking
ProQuest Women's & Gender Studies - hybrid linking
ProQuest Central Essentials - QC
ProQuest Central
Business Premium Collection
ProQuest One Business - hybrid linking
ProQuest One Business (Alumni) - hybrid linking
ProQuest One Community College
ProQuest Central
Business Premium Collection (Alumni)
ABI/INFORM Global (Corporate)
ProQuest Business Collection (Alumni Edition)
ProQuest Business Collection
ABI/INFORM Professional Advanced
ABI/INFORM Global
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest One Academic Middle East (New)
ProQuest One Business
ProQuest One Business (Alumni)
ProQuest Central - hybrid linking
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ABI/INFORM Global (Corporate)
ProQuest Business Collection (Alumni Edition)
ProQuest One Business
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
ProQuest One Community College
ABI/INFORM Complete
ProQuest Central
ABI/INFORM Professional Advanced
ProQuest Central Korea
ProQuest Central (New)
ABI/INFORM Complete (Alumni Edition)
Business Premium Collection
ABI/INFORM Global
ABI/INFORM Global (Alumni Edition)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Business Collection
ProQuest One Academic UKI Edition
ProQuest One Business (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Business Premium Collection (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Biology
EISSN 1095-9203
ExternalDocumentID 32409444
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
Working Paper/Pre-Print
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI137523
– fundername: NIAID NIH HHS
  grantid: R01 AI126587
– fundername: NIAID NIH HHS
  grantid: P30 AI036214
– fundername: NIAID NIH HHS
  grantid: R01 AI102766
– fundername: NIAID NIH HHS
  grantid: R01 AI136756
– fundername: NCATS NIH HHS
  grantid: UL1 TR001442
– fundername: NIAID NIH HHS
  grantid: R41 AI147929
GroupedDBID ---
--Z
-DZ
-ET
-~X
.-4
..I
.55
.DC
08G
0R~
0WA
123
18M
2FS
2KS
2WC
34G
36B
39C
3R3
53G
5RE
66.
6OB
6TJ
7X2
7~K
85S
8F7
AABCJ
AACGO
AAIKC
AAMNW
AANCE
AAWTO
ABCQX
ABDBF
ABDEX
ABDQB
ABEFU
ABIVO
ABJNI
ABOCM
ABPLY
ABPPZ
ABQIJ
ABTLG
ABWJO
ABZEH
ACBEA
ACBEC
ACGFO
ACGFS
ACGOD
ACIWK
ACMJI
ACNCT
ACPRK
ACQOY
ACUHS
ADDRP
ADUKH
AEGBM
AENEX
AETEA
AFFNX
AFHKK
AFQFN
AFRAH
AGFXO
AGNAY
AGSOS
AHMBA
AIDAL
AIDUJ
AJGZS
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
BKF
BLC
C45
CGR
CS3
CUY
CVF
DB2
DU5
EBS
ECM
EIF
EMOBN
F5P
FA8
FEDTE
GX1
HZ~
I.T
IAO
IEA
IGS
IH2
IHR
INH
INR
IOF
IOV
IPO
IPY
ISE
JCF
JLS
JSG
JST
K-O
KCC
L7B
LSO
LU7
M0P
MQT
MVM
N9A
NEJ
NHB
NPM
O9-
OCB
OFXIZ
OGEVE
OK1
OMK
OVD
P-O
P2P
PQQKQ
PZZ
QS-
RHI
RXW
SC5
SJN
TAE
TEORI
TN5
TWZ
UBW
UCV
UHB
UIG
UKR
UMD
UNMZH
UQL
USG
VVN
WH7
WI4
X7M
XJF
XZL
Y6R
YCJ
YK4
YKV
YNT
YOJ
YR2
YR5
YRY
YSQ
YV5
YWH
YYP
YZZ
ZCA
ZE2
~02
~G0
~KM
~ZZ
3V.
7WY
7XB
8FK
8FL
ABUWG
AFKRA
AZQEC
BENPR
BEZIV
CCPQU
DWQXO
FRNLG
K60
K6~
L.-
M0C
PHGZM
PHGZT
PIMPY
PKEHL
PQBIZ
PQBZA
PQEST
PQUKI
Q9U
2XV
7X8
ADXHL
AEUPB
AFBNE
ID FETCH-LOGICAL-c549t-dbf0f4ea2c4042f60d1b4fdf1b84b8410f74fa4810d08a92ca73fc1ffe63539e3
IEDL.DBID M0C
ISICitedReferencesCount 146
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000535608300038&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1095-9203
IngestDate Sun Sep 28 11:37:06 EDT 2025
Mon Jun 30 17:06:43 EDT 2025
Thu Apr 03 07:02:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6492
Language English
License Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c549t-dbf0f4ea2c4042f60d1b4fdf1b84b8410f74fa4810d08a92ca73fc1ffe63539e3
Notes SourceType-Working Papers-1
ObjectType-Working Paper/Pre-Print-1
content type line 50
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-8158-4508
0000-0001-5238-9685
0000-0002-1306-4324
0000-0003-0790-1277
0000-0001-5210-4387
0000-0001-8433-5382
0000-0002-7361-4885
0000-0002-3664-0072
0000-0001-5545-6871
0000-0002-1690-0447
0000-0002-4591-5373
0000-0002-2595-3188
0000-0003-3087-8677
0000-0002-8443-6017
0000-0002-7377-8636
0000-0002-4548-7241
0000-0001-8331-4344
0000-0001-7602-3995
0000-0002-5901-3856
0000-0002-4883-6910
0000-0002-6772-0155
OpenAccessLink https://www.proquest.com/docview/2586569032?pq-origsite=%requestingapplication%
PMID 32409444
PQID 2586569032
PQPubID 2036240
ParticipantIDs proquest_miscellaneous_2404046282
proquest_journals_2586569032
pubmed_primary_32409444
PublicationCentury 2000
PublicationDate 2020-05-15
PublicationDateYYYYMMDD 2020-05-15
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-15
  day: 15
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: St. Louis
PublicationTitle IDEAS Working Paper Series from RePEc
PublicationTitleAlternate Science
PublicationYear 2020
Publisher Federal Reserve Bank of St. Louis
Publisher_xml – name: Federal Reserve Bank of St. Louis
References 33674794 - Nat Methods. 2021 Mar;18(3):233. doi: 10.1038/s41592-021-01097-4
References_xml – reference: 33674794 - Nat Methods. 2021 Mar;18(3):233. doi: 10.1038/s41592-021-01097-4
SSID ssj0009593
Score 2.6467464
Snippet De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
SubjectTerms Amino Acid Motifs
Antibodies, Neutralizing - biosynthesis
Computational Biology - methods
Humans
Immunodominant Epitopes - chemistry
Immunodominant Epitopes - immunology
Protein Conformation
Protein Engineering - methods
Proteins
Recombinant Fusion Proteins - chemistry
Recombinant Fusion Proteins - immunology
Respiratory Syncytial Virus Vaccines - chemistry
Respiratory Syncytial Virus Vaccines - immunology
Respiratory Syncytial Virus, Human - immunology
Single-Domain Antibodies - chemistry
Single-Domain Antibodies - immunology
Vaccines
Title De novo protein design enables the precise induction of RSV-neutralizing antibodies
URI https://www.ncbi.nlm.nih.gov/pubmed/32409444
https://www.proquest.com/docview/2586569032
https://www.proquest.com/docview/2404046282
Volume 368
WOSCitedRecordID wos000535608300038&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT8IwEG8EfPBJjV8okpr4Wl23snVPJiJEEyEL-AFPpNuuCS8bMiDRv95rGeqLvpgsfdhdmuZ6be-u198Rcol-jy95IhmA8pnQqWCx8hTzfAVOrCH2EzvTj0G_L0ejMCoDbkWZVrnZE-1GneaJiZFfuy2JpkfoeO7N7I2ZqlHmdrUsoVEhNWPZmJS-ntMuEXx-vI25Uuodyfx3M9IeJ93d_w5kj9QiNYP5PtmC7IAM74Bm-SqnFnRhmtHUpmVQsO-iCoo2HpJMMR2g6IKv8WJprulg-MIyWNpgxweeYRTFPI1zk1h4SJ67naf2PSuLJbAEXbwFS2PtaAHKTQSuQ-07KY9R9JrHUuDHHR0IrYTkTupIFbqJCjydcK0BTQ4vBO-IVLM8gxNCFTJ6vvEdw9TAq4Uy9lKOixsCnHDu10ljI5lJqfHF5FssdXLxRUZdNRcQKoN8iTw4NPsYFnmO19KfzNagGhMDDBgKIU7_7vyM7LjG4zX4qa0GqS7mSzgn28lqMS3mTVIJXsemHckmqd12-tGgaVUC237Uw3_RQy8afwKQOcSn
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V07T8MwED5BQYIJEK9CASPBaIgTN48BMfAQiFIhXmILTnyWuiSlL1R-FL-Rs9sCC2wMSNlsWRfd2777DmCP8p4wFnnMEVXIpdGSZypQPAgVepnBLMwdpxtRsxk_PSU3U_A-6YWxZZUTm-gMtS5ze0d-6NdjCj0SL_CP2y_cTo2yr6uTERojsbjC4SulbN2jy1Pi777vn5_dn1zw8VQBnlMu1OM6M56RqPxcksCa0NMiIxqNyGJJn_BMJI2SsfC0F6vEz1UUmFwYg-SbgwQDOncaZqQk9bClgt7JGDHoWy_OgVJDCi3Ez2Grc1_nC__txxdh5ka1sbMEU1gsw90psqIclMyBSrQKpl3ZCUPX99VlFMPSkh0WhKxV6BEeLisNu7175AX23WXOG_loRmLUykpbOLkCD39C_SpUirLAdWCKNgahzY0TbeHjkjgLtCDjhREJtAirUJtwIh1rdDf9YkMVdj-XSRftA4sqsOzTHiLNNfvSnrURt9P2CDQktcCHiZRy4_fDd2Du4v66kTYum1ebMO_b7N5ixdZrUOl1-rgFs_mg1-p2tp3oMXj-a5Z_ADIKHSg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=De+novo+protein+design+enables+the+precise+induction+of+RSV-neutralizing+antibodies&rft.jtitle=IDEAS+Working+Paper+Series+from+RePEc&rft.au=Sesterhenn%2C+Fabian&rft.au=Yang%2C+Che&rft.au=Bonet%2C+Jaume&rft.au=Cramer%2C+Johannes+T&rft.date=2020-05-15&rft.pub=Federal+Reserve+Bank+of+St.+Louis&rft_id=info:doi/10.1126%2Fscience.aay5051
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1095-9203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1095-9203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1095-9203&client=summon